FMI
TWST icon

F/M Investments’s Twist Bioscience TWST Stock Holding History

F/M Investments’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
18,050
+200
+1% +$13K 0.09% 125
2026
Q1 		$848K Buy
+17,850
New +$800K 0.06% 181

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

F/M Investments's TWST Position: Q2 2026 in Review

F/M Investments increased its Twist Bioscience (TWST) stake by 1.1% in Q2 2026, buying an estimated $13K and bringing the position to 18,050 shares worth $1.86M. The position accounts for 0.09% of the portfolio, ranked #125.

F/M Investments first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • F/M Investments held 18,050 shares of Twist Bioscience worth $1.86M as of Q2 2026.
  • F/M Investments bought 200 Twist Bioscience shares in Q2 2026, an estimated $13K.
  • Twist Bioscience made up 0.09% of F/M Investments's portfolio in Q2 2026, its #125 holding.
  • F/M Investments first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.